Medcorp Limited (TTSE:MED)
Trinidad and Tobago · Delayed Price · Currency is TTD 32.00
-0.50 (-1.54%)
At close: Sep 4, 2026
Medcorp Income Statement
Financials in millions TTD. Fiscal year is January - December.
Millions TTD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 123.89 | 121.7 | 122.24 | 127.02 | 122.22 | 114.19 | |
Revenue Growth | 37.75% | -0.44% | -3.76% | 3.92% | 7.03% | 10.46% |
Cost of Revenue | 64.78 | 60.03 | 59.68 | 56 | 61.81 | 56.05 |
Gross Profit | 59.11 | 61.67 | 62.55 | 71.02 | 60.41 | 58.14 |
Selling, General & Admin | 42.48 | 41.04 | 38.64 | 33.24 | 32.08 | 28.4 |
Other Operating Expenses | -1.41 | -1.68 | 0.55 | -1.66 | -3.19 | -5.25 |
Operating Expenses | 41.07 | 39.36 | 39.19 | 31.59 | 28.89 | 23.15 |
Operating Income | 18.04 | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 |
Interest Expense | -3.76 | -4.34 | -5.95 | -3.21 | -2.45 | -2.31 |
Interest & Investment Income | - | - | - | 30.69 | - | - |
Earnings From Equity Investments | 2.83 | 2.45 | 4.83 | 4.98 | 1.72 | 1.99 |
EBT Excluding Unusual Items | 17.11 | 20.42 | 22.24 | 71.89 | 30.79 | 34.66 |
Gain (Loss) on Sale of Assets | - | - | - | -0 | 0.12 | - |
Pretax Income | 17.11 | 20.42 | 22.24 | 71.89 | 30.91 | 34.66 |
Income Tax Expense | -1.01 | 2.24 | 6.86 | 14.82 | 6.78 | 10.17 |
Net Income | 18.12 | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 |
Net Income to Common | 18.12 | 18.18 | 15.38 | 57.07 | 24.13 | 24.49 |
Net Income Growth | 389.09% | 18.21% | -73.05% | 136.53% | -1.49% | 38.74% |
Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 7 | 7 |
Shares Change | 4.34% | 2.34% | - | - | - | - |
EPS (Basic) | 2.32 | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 |
EPS (Diluted) | 2.32 | 2.37 | 2.06 | 7.63 | 3.23 | 3.27 |
EPS Growth | 368.74% | 15.51% | -73.05% | 136.53% | -1.49% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 23.22 | 22.76 | 20.12 | 28.71 | 25.41 | 5.66 |
Free Cash Flow Per Share | 2.97 | 2.97 | 2.69 | 3.84 | 3.40 | 0.76 |
Dividend Per Share | 2.000 | 2.000 | 4.000 | - | - | 4.500 |
Dividend Growth | -50.00% | -50.00% | - | - | - | - |
Gross Margin | 47.71% | 50.67% | 51.17% | 55.92% | 49.43% | 50.91% |
Operating Margin | 14.56% | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% |
Profit Margin | 14.63% | 14.94% | 12.58% | 44.93% | 19.74% | 21.45% |
Free Cash Flow Margin | 18.74% | 18.70% | 16.46% | 22.60% | 20.79% | 4.96% |
EBITDA | 22.82 | 27.05 | 28.55 | 44.62 | 36.67 | 36.91 |
EBITDA Margin | 18.42% | 22.23% | 23.36% | 35.13% | 30.00% | 32.32% |
D&A For EBITDA | 4.78 | 4.74 | 5.19 | 5.18 | 5.14 | 1.92 |
EBIT | 18.04 | 22.31 | 23.36 | 39.43 | 31.52 | 34.99 |
EBIT Margin | 14.56% | 18.33% | 19.11% | 31.05% | 25.79% | 30.64% |
Effective Tax Rate | - | 10.96% | 30.86% | 20.62% | 21.94% | 29.34% |
Advertising Expenses | - | 0.28 | 0.24 | 0.17 | 0.2 | 0.14 |